These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21713999)

  • 21. Severe myoclonus-dystonia syndrome associated with a novel epsilon-sarcoglycan gene truncating mutation.
    Maréchal L; Raux G; Dumanchin C; Lefebvre G; Deslandre E; Girard C; Campion D; Parain D; Frebourg T; Hannequin D
    Am J Med Genet B Neuropsychiatr Genet; 2003 May; 119B(1):114-7. PubMed ID: 12707948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myoclonus-dystonia due to maternal uniparental disomy.
    Guettard E; Portnoi MF; Lohmann-Hedrich K; Keren B; Rossignol S; Winkler S; El Kamel I; Leu S; Apartis E; Vidailhet M; Klein C; Roze E
    Arch Neurol; 2008 Oct; 65(10):1380-5. PubMed ID: 18852357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Earlier onset of motor deficits in mice with double mutations in Dyt1 and Sgce.
    Yokoi F; Yang G; Li J; DeAndrade MP; Zhou T; Li Y
    J Biochem; 2010 Oct; 148(4):459-66. PubMed ID: 20627944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity.
    Valente EM; Misbahuddin A; Brancati F; Placzek MR; Garavaglia B; Salvi S; Nemeth A; Shaw-Smith C; Nardocci N; Bentivoglio AR; Berardelli A; Eleopra R; Dallapiccola B; Warner TT
    Mov Disord; 2003 Sep; 18(9):1047-51. PubMed ID: 14502674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene.
    Asmus F; Salih F; Hjermind LE; Ostergaard K; Munz M; Kühn AA; Dupont E; Kupsch A; Gasser T
    Ann Neurol; 2005 Nov; 58(5):792-7. PubMed ID: 16240355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epsilon-sarcoglycan gene in myoclonic syndromes.
    Valente EM; Edwards MJ; Mir P; DiGiorgio A; Salvi S; Davis M; Russo N; Bozi M; Kim HT; Pennisi G; Quinn N; Dallapiccola B; Bhatia KP
    Neurology; 2005 Feb; 64(4):737-9. PubMed ID: 15728306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Japanese familial case of myoclonus-dystonia syndrome with a splicing mutation in SGCE.
    Wada T; Takano K; Tsurusaki Y; Miyake N; Nakashima M; Saitsu H; Matsumoto N; Osaka H
    Pediatr Int; 2015 Apr; 57(2):324-6. PubMed ID: 25868953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myoclonus-dystonia and epilepsy in a family with a novel epsilon-sarcoglycan mutation.
    Haugarvoll K; Tzoulis C; Tran GT; Karlsen B; Engelsen BA; Knappskog PM; Bindoff LA
    J Neurol; 2014 Feb; 261(2):358-62. PubMed ID: 24297365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mutation of the epsilon-sarcoglycan gene in a Chinese family with myoclonus-dystonia syndrome.
    Chen XP; Zhang YW; Zhang SS; Chen Q; Burgunder JM; Wu SH; Yang Y; Luo ZM; Shang HF
    Mov Disord; 2008 Jul; 23(10):1472-5. PubMed ID: 18581468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical phenotype heterogeneity in a family with ε-sarcoglycan gene mutation.
    Kaczyńska J; Jamrozik Z; Szubiga M; Rudzińska-Bar M; Janik P
    Neurol Neurochir Pol; 2020; 54(1):33-38. PubMed ID: 31956970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A gain-of-glycosylation mutation associated with myoclonus-dystonia syndrome affects trafficking and processing of mouse ε-sarcoglycan in the late secretory pathway.
    Waite A; De Rosa MC; Brancaccio A; Blake DJ
    Hum Mutat; 2011 Nov; 32(11):1246-58. PubMed ID: 21796726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A mixed-ethnicity myoclonus-dystonia patient with a novel SGCE nonsense mutation: a case report.
    de Leon MAJ; Rosales RL; Klein C; Westenberger A
    BMC Neurol; 2022 Jan; 22(1):11. PubMed ID: 34986800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype.
    Asmus F; Zimprich A; Tezenas Du Montcel S; Kabus C; Deuschl G; Kupsch A; Ziemann U; Castro M; Kühn AA; Strom TM; Vidailhet M; Bhatia KP; Dürr A; Wood NW; Brice A; Gasser T
    Ann Neurol; 2002 Oct; 52(4):489-92. PubMed ID: 12325078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel conserved mutation in SGCE gene in 3 unrelated patients with classical phenotype myoclonus-dystonia syndrome.
    Szubiga M; Rudzińska M; Bik-Multanowski M; Pietrzyk JJ; Szczudlik A
    Neurol Res; 2013 Jul; 35(6):659-62. PubMed ID: 23561547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal nuclear envelopes in the striatum and motor deficits in DYT11 myoclonus-dystonia mouse models.
    Yokoi F; Dang MT; Zhou T; Li Y
    Hum Mol Genet; 2012 Feb; 21(4):916-25. PubMed ID: 22080833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myoclonus-dystonia: Distinctive motor and non-motor phenotype from other dystonia syndromes.
    Timmers ER; Smit M; Kuiper A; Bartels AL; van der Veen S; van der Stouwe AMM; Santens P; Bergmans B; Tijssen MAJ
    Parkinsonism Relat Disord; 2019 Dec; 69():85-90. PubMed ID: 31706131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical differentiation of genetically proven benign hereditary chorea and myoclonus-dystonia.
    Asmus F; Devlin A; Munz M; Zimprich A; Gasser T; Chinnery PF
    Mov Disord; 2007 Oct; 22(14):2104-9. PubMed ID: 17702043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence.
    Saunders-Pullman R; Shriberg J; Heiman G; Raymond D; Wendt K; Kramer P; Schilling K; Kurlan R; Klein C; Ozelius LJ; Risch NJ; Bressman SB
    Neurology; 2002 Jan; 58(2):242-5. PubMed ID: 11805251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric writer's cramp in myoclonus-dystonia: maternal imprinting hides positive family history.
    Gerrits MC; Foncke EM; Koelman JH; Tijssen MA
    Eur J Paediatr Neurol; 2009 Mar; 13(2):178-80. PubMed ID: 18571946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Favorable response to carbamazepine therapy in genetically proven myoclonus-dystonia child.
    Aljabri MF; Kamal NM; Alghamdi A; Alghamdi H; Alomairi N
    Ital J Pediatr; 2021 Feb; 47(1):33. PubMed ID: 33588860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.